Supplemental Figure 5 from A Personalized Therapeutic Approach for Liver Cancers Expressing the African-Centric P47S Variant of TP53
Year: 2026
Type: supplementary-materials
Abstract: Figure S5. Inhibition of PIN1 activity underlies enhanced lexibulin sensitivity.
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7167022682
Cites:
Cited by:
Related to:
